Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets.
about
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesNoncoding RNAs and neurobehavioral mechanisms in psychiatric diseaseThe schizophrenia risk gene product miR-137 alters presynaptic plasticity.Neurodevelopment in schizophrenia: the role of the wnt pathways.Potential Impact of miR-137 and Its Targets in Schizophrenia.Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.Large-scale interaction effects reveal missing heritability in schizophrenia, bipolar disorder and posttraumatic stress disorder.MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variantThe impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjectsExperimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137.Transcriptome-wide discovery of microRNA binding sites in human brain.Genetic architectures of psychiatric disorders: the emerging picture and its implications.Association of a miRNA-137 polymorphism with schizophrenia in a Southern Chinese Han population.The genomics of schizophrenia: update and implications.MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.Heterogeneity and individuality: microRNAs in mental disorders.Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysisNo effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure.Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder.Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder.Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137.Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia riskZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human OriginDysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder.Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivationMicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets.Genetic Evaluation of Schizophrenia Using the Illumina HumanExome ChipNo association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population.miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome.Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals.Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia.A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific ExpressionAnalysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortexMicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients.Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders.Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.miR-137: a new player in schizophrenia.
P2860
Q21261478-B427A18C-2E1A-4113-A2A4-D2E424F6301CQ26744819-2533875F-A99A-4E73-B48B-0D7C800F50E2Q26851626-40D6C358-74FF-4EB9-A0A6-C74692EE37E6Q27312392-92FE33A7-6AF1-4998-88DA-030286A27EABQ30442237-BAD12FC8-162C-49F6-96A1-5F2BB1425D4BQ30454963-EA9DDFAB-9A13-4D87-AECD-8CFAF942FD24Q33627250-5E7AC6A5-9E02-41CD-859B-DFCBB5CF5FA5Q33635688-A555FEDE-7A98-4BCD-868A-7F9291C871C9Q33676705-248729D9-2D97-4CBB-BE0A-193A67EE2945Q33923604-7A3D31A6-9BD7-4B06-8F22-34E9958AA212Q33924728-AF0316E7-7765-4596-9F08-17AE8152F97AQ33940022-60A66B4E-226C-44B2-9A34-192AAE47D05FQ33949729-3DD24322-8258-42E1-AC5F-92FEE7A177F0Q34177537-AE5A2DF6-3937-448F-A75C-E8BA3C9AF93EQ34381708-F2E890F0-3CB2-4436-AAD7-5ACC99A6BB23Q34394249-14A081A5-A2BC-48CA-9092-5BB639CCA463Q34447816-080CC62B-3E92-4094-8EF6-F76FA10803F2Q34458640-BD66048A-70C7-4B8A-AED0-3DC3868B4EB8Q34578760-F55DD0DB-7705-4D24-87EE-652F52BB0AFAQ34603780-510EE578-F905-4D96-9D0A-DDE31878BE4FQ34657883-3A8A077C-B2C5-449B-AA1D-60A242EFFAEBQ35079675-78F08B02-76F3-472E-AA45-3C33F56B4D8BQ35369598-F829ADBF-9067-4636-9D1D-9A43F64B3CB6Q35489742-06F048C9-BA36-4964-AD51-2197FA0701A5Q35533016-56404CD1-60E1-4B17-9266-6BD3DE20E7BDQ35553863-FD66D7F3-3EDC-4CB1-A053-3F1CA9E1E70FQ35596962-0AF2A926-18E5-4845-9966-4C26276A5DECQ35691087-34D61B81-C98A-4DBB-B96A-F9ABBF71C20AQ35731566-62538679-CE75-4DF0-BCA8-8861650B33E9Q35974121-A6863D9B-2EF1-47CA-A4DF-34AE5791730CQ36067795-4F13EC77-6CC2-417B-A8A6-DCCC86BF3895Q36463734-0F3029CB-D436-492A-9CE4-F62864178422Q36837420-DE0EAB84-FDC4-4647-880D-46044FACACFBQ36915423-CDD225F7-4E89-4A28-B273-9E0614E4B5D3Q36994815-008DCC91-1E60-409D-8D23-9CAFC973584EQ37120426-FF5A2B1F-0D33-4524-B46E-C3B9601BA581Q37363559-A7CB3438-1429-4678-8C3E-BDAC920E63A6Q37496956-F035C9C8-2303-475F-817C-744B6DB7DE7CQ37505070-E2C9F67A-0397-4047-A17A-3138D0D3CE34Q37645440-E7D9FA89-D152-4D3D-8FB5-80DE052F6A16
P2860
Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@en
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@nl
type
label
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@en
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@nl
prefLabel
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@en
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@nl
P2093
P2860
P356
P1433
P1476
Validation of schizophrenia-as ...... C and TCF4 as miR-137 targets.
@en
P2093
P2860
P2888
P356
10.1038/MP.2011.170
P407
P577
2011-12-20T00:00:00Z
P6179
1043494035